Skip to content
GLP-1 Decoder

Ozempic for Type 2 Diabetes: Evidence, Eligibility, Coverage

Yes. Ozempic is FDA approved for type 2 diabetes: for adults with type 2 diabetes, it lowers blood sugar when used with diet and exercise. In STEP 2, people on Wegovy lost 9.6% of body weight on average, vs 3.4% on placebo.

For type 2 diabetes
FDA approved
Active ingredient
semaglutide
How it is taken
weekly injection
Best result (STEP 2)
9.6% weight loss

Ozempic: quick facts

Time it remains in your body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week. After 7 d, half is gone, and by five half-lives (35 d), only about 3% is left.

Main trial weight loss
Ozempic (SUSTAIN 1)4.7 kgPlacebo1.2 kg

In SUSTAIN 1, people with type 2 diabetes lost 4.7 kg over 30 weeks, compared with 1.2 kg in the placebo group.

Costs over time
202520262027$1,027.51$0List priceSelf-pay

Monthly prices in US dollars include the list price and self-pay offers, with each figure read from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

Who qualifies?

Ozempic: who qualifies for treatment
SourceWho qualifies
FDA labelFor adults with type 2 diabetes, it lowers blood sugar when used with diet and exercise.
FDA labelIt lowers the chance of a heart attack, stroke or death related to the heart in adults who have type 2 diabetes as well as heart disease.
FDA labelFor adults with type 2 diabetes and also chronic kidney disease, it lowers the chance that kidney disease worsens, kidney failure occurs, or heart-related death happens.

Label source: FDA label (DailyMed).

Type 2 diabetes: trial results

There is no Ozempic trial in this group. These trials involve other brands with the same ingredient.

Trials involving the same ingredient (semaglutide)
TrialMedicineWho took partLengthPeopleMain resultComparison
STEP 2 WegovyAdults with obesity or overweight who also have type 2 diabetes68 weeks1,2109.6% weight loss3.4% on placebo

Trial sources: STEP 2 (PubMed).

What changes for you if you have type 2 diabetes?

Ozempic: label details for type 2 diabetes
What changesWhat the label says
Diabetic Retinopathy ComplicationsIn people with type 2 diabetes, diabetic eye disease can get worse, especially when blood sugar falls fast. Eye checks matter if you already have it.
Hypoglycemia When Used With Insulin Secretagogues or InsulinTaking it with insulin or a sulfonylurea increases the chance of low blood sugar, so those doses may need to be lowered.
Taken with insulin or sulfonylureasYour doctor may lower the doses when you take it with insulin or a sulfonylurea, including glipizide or glimepiride. This combination raises the chance of low blood sugar.

Taken from the FDA labels: FDA label (DailyMed).

The label warnings appear in the FDA label on DailyMed.

Coverage for type 2 diabetes

Medicare Part D can cover these medicines when they are prescribed for diabetes or cardiovascular disease.

Sources: humana.com.

Alternatives for type 2 diabetes

Type 2 diabetes: GLP-1 medicines
MedicineFor type 2 diabetesHow it is takenTrial result
OzempicFDA approvedweekly injectionNot listed
RybelsusFDA approveddaily tabletNot listed
MounjaroFDA approvedweekly injectionA1C down 2.3 points
TrulicityFDA approvedweekly injectionA1C down 1.77 points
VictozaFDA approveddaily injectionNot listed
ByettaFDA approvedtwice-daily injectionNot listed
WegovyNot an approved useweekly injection or daily tablet9.6% weight loss
ZepboundNot an approved useweekly injection14.7% weight loss
FoundayoNot an approved usedaily tablet9.6% weight loss
SaxendaNot an approved usedaily injection7.4% weight loss

Sources: FDA label (DailyMed), PubMed.

Questions to discuss with your prescriber

Read all of the Ozempic prescribing information on DailyMed.